TrialGPT hits 87.3% accuracy, trims screening time 42.6%

The survey organizes clinical-trial AI into four families. Natural language processing mines the text-heavy material — protocols, investigator's brochures, medical records and eligibility criteria — to find eligible patients far faster than manual review, though clinical text is dense with abbreviations and needs models trained on medical data. Generative AI covers synthetic patient data that is statistically similar to real data but de-identified, protocol and SAP drafting, trial simulation, and testing of trial software; the stated catch is that synthetic data must be rigorously checked against real-data trends. Computer vision handles tumor scans, retinal photos, pathology slides and motion video, but the guide notes that using it for primary endpoints requires strict validation against expert assessment and, in some cases, approval as medical device software. Predictive models and machine learning are aimed at operational choices such as site selection, dropout and safety risk, dose optimization, adaptive design and enrollment forecasting, with the caveat that predictions are probabilistic and errors can misallocate resources.

The model examples are where the concrete results sit. TrialMind is a generative platform spanning hypothesis generation through conduct and reporting, built on the Panacea foundation model trained on clinical trial data and literature. AutoTrial was trained on data built from roughly 400,000 clinical trials and specializes in trial design, helping draft eligibility criteria. TrialGPT is aimed at patient matching. FairPlay uses counterfactual simulation as a digital twin to correct bias in electronic health record data, and the author also lists Trial2Vec, HINT and SPOT among published research on patient matching and trial-outcome prediction.

Across all of these, the guide says regulator acceptance is still developing and adds data privacy, underrepresentation of women, minorities and older adults in trial data, and integration with existing workflows and systems as open issues.